| Titre : | Reevaluating the benefits of folic acid fortification in the United States : Economic analysis, regulation, and public health. (2005) |
| Auteurs : | Scott-D GROSSE ; Joseph MULINARE ; ROMANO (Patrick-S) : USA. Division of General Medicine and Center for Health Services Research in Primary Care. Universe of California. Davis Sacramento. ; WAITZMAN (Norman-J) : USA. Department of Economics. University of Utah. Salt Lake City. |
| Type de document : | Article |
| Dans : | American journal of public health (vol. 95, n° 11, 2005) |
| Pagination : | 1917-1922 |
| Langues: | Anglais |
| Mots-clés : | Etats Unis ; Amérique ; Analyse économique ; Céréale ; Foetopathie ; Supplémentation ; Economie santé ; Projet loi ; Homme ; Prévention santé ; Analyse coût avantage ; Politique santé ; Vitamine ; Malformation ; Rachis [pathologie] ; Système ostéoarticulaire [pathologie] ; Système nerveux [pathologie] ; Gestation [pathologie] ; Amérique du Nord |
| Résumé : | [BDSP. Notice produite par INIST-CNRS fALfOR0x. Diffusion soumise à autorisation]. Before a 1996 US regulation requiring fortification of enriched cereal-grain products with folic acid, 3 economic evaluations projected net economic benefits or cost savings of folic acid fortification resulting from the prevention of pregnancies affected by a neural tube defect. Because the observed decline in neural tube defect rates is greater than was forecast before fortification, the economic gains are correspondingly larger. Applying both cost-benefit and cost-effectiveness analytic techniques, we estimated that folic acid fortification is associated with annual economic benefit of $312 million to $425 million. The cost savings (net reduction in direct costs) were estimated to be in the range of $88 million to $145 million per year. |

